Cargando…
PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429213/ http://dx.doi.org/10.1097/01.HS9.0000975624.80756.cf |
| _version_ | 1785090654371577856 |
|---|---|
| author | Lucijanic, Marko Krecak, Ivan Soric, Ena Sabljic, Anica Galusic, Davor Holik, Hrvoje Perisa, Vlatka Perić, Martina Morić Zekanovic, Ivan Kušec, Rajko |
| author_facet | Lucijanic, Marko Krecak, Ivan Soric, Ena Sabljic, Anica Galusic, Davor Holik, Hrvoje Perisa, Vlatka Perić, Martina Morić Zekanovic, Ivan Kušec, Rajko |
| author_sort | Lucijanic, Marko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429213 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104292132023-08-17 PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED Lucijanic, Marko Krecak, Ivan Soric, Ena Sabljic, Anica Galusic, Davor Holik, Hrvoje Perisa, Vlatka Perić, Martina Morić Zekanovic, Ivan Kušec, Rajko Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429213/ http://dx.doi.org/10.1097/01.HS9.0000975624.80756.cf Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Lucijanic, Marko Krecak, Ivan Soric, Ena Sabljic, Anica Galusic, Davor Holik, Hrvoje Perisa, Vlatka Perić, Martina Morić Zekanovic, Ivan Kušec, Rajko PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED |
| title | PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED |
| title_full | PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED |
| title_fullStr | PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED |
| title_full_unstemmed | PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED |
| title_short | PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED |
| title_sort | pb2220: atrial fibrillation is frequent in patients with myelofibrosis and might be sub-optimally treated |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429213/ http://dx.doi.org/10.1097/01.HS9.0000975624.80756.cf |
| work_keys_str_mv | AT lucijanicmarko pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT krecakivan pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT soricena pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT sabljicanica pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT galusicdavor pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT holikhrvoje pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT perisavlatka pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT pericmartinamoric pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT zekanovicivan pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated AT kusecrajko pb2220atrialfibrillationisfrequentinpatientswithmyelofibrosisandmightbesuboptimallytreated |